ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
135,488,140
Total 13F shares
99,701,045
Share change
+1,798,039
Total reported value
$1,874,384,692
Put/Call ratio
94%
Price per share
$18.80
Number of holders
267
Value change
+$32,738,534
Number of buys
120
Number of sells
125

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q4 2024

As of 31 Dec 2024, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 267 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,701,045 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Slate Path Capital LP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, Siren, L.L.C., T. Rowe Price Investment Management, Inc., and NORGES BANK. This page lists 267 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.